99-30705. Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 64, Number 227 (Friday, November 26, 1999)]
    [Notices]
    [Page 66481]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-30705]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Radiological Devices Panel of the Medical Devices Advisory 
    Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
         This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Radiological Devices Panel of the Medical 
    Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA's regulatory issues.
        Date and Time: The meeting will be held on December 16, 1999, 8:30 
    a.m. to 5 p.m.
        Location: DoubleTree Hotel, Plaza Ballroom, 1750 Rockville Pike, 
    Rockville, MD.
        Contact Person: Robert J. Doyle, Center for Devices and 
    Radiological Health (HFZ-470), Food and Drug Administration, 9200 
    Corporate Blvd. Rockville, MD 20850, 301-594-1212, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12526. Please call the Information Line for 
    up-to-date information on this meeting.
        Agenda: The committee will discuss, make recommendations, and vote 
    on a premarket approval application for a digital mammography device.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by December 8, 
    1999. Oral presentations from the public will be scheduled between 
    approximately 8:45 a.m. and 9:15 a.m. Near the end of the committee 
    deliberations, a 30 minute open public session will be conducted for 
    interested persons to address issues specific to the submission before 
    the committee. Time allotted for each presentation may be limited. 
    Those desiring to make formal oral presentations should notify the 
    contact person before December 8, 1999, and submit a brief statement of 
    the general nature of the evidence or arguments they wish to present, 
    the names and addresses of proposed participants, and an indication of 
    the approximate time requested to make their presentation.
         Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: November 15, 1999.
    Linda A. Suydam,
    Senior Associate Commissioner.
    [FR Doc. 99-30705 Filed 11-24-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/26/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-30705
Pages:
66481-66481 (1 pages)
PDF File:
99-30705.pdf